BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 18181739)

  • 1. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
    Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
    Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy.
    Aslan T; Fassas AB; Desikan R; Siegel D; Munshi N; Mehta J; Singhal S; Barlogie B; Anaissie E
    Bone Marrow Transplant; 1999 Sep; 24(5):505-9. PubMed ID: 10482934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
    Wendt CH; Hertz MI
    Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy.
    Gerna G; Campanini G; Rognoni V; Marchi A; Rovida F; Piralla A; Percivalle E
    J Clin Virol; 2008 Jan; 41(1):45-8. PubMed ID: 18082444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT.
    Anak S; Atay D; Unuvar A; Garipardic M; Agaoglu L; Ozturk G; Karakas Z; Devecioglu O
    Pediatr Pulmonol; 2010 Mar; 45(3):307-11. PubMed ID: 20146398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.
    Hynicka LM; Ensor CR
    Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
    McCarthy AJ; Kingman HM; Kelly C; Taylor GS; Caul EO; Grier D; Moppett J; Foot AB; Cornish JM; Oakhill A; Steward CG; Pamphilon DH; Marks DI
    Bone Marrow Transplant; 1999 Dec; 24(12):1315-22. PubMed ID: 10627641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
    El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
    Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
    Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment.
    Abdallah A; Rowland KE; Schepetiuk SK; To LB; Bardy P
    Bone Marrow Transplant; 2003 Jul; 32(2):195-203. PubMed ID: 12838285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
    Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
    Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
    Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
    Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.
    Khanna N; Steffen I; Studt JD; Schreiber A; Lehmann T; Weisser M; Flückiger U; Gratwohl A; Halter J; Hirsch HH
    Transpl Infect Dis; 2009 Apr; 11(2):100-5. PubMed ID: 19175540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
    Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
    Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.